Company: TCBI
Filing Date: 2025-03-06
Form Type: DEF 14A
Source: 0001077428-25-000066
Chunk: 111

Company: TEXAS CAPITAL BANCSHARES INC/TX
Filing Date: 2025-03-06
Form: DEF 14A
Chunk 111
---
 million share increase, less any shares granted or awarded since year-end). We expect this amount to last for approximately three years of awards. While we believe this modeling provides a reasonable estimate of how long such a share reserve would last, there are a number of factors that could impact our future equity share usage. Among the factors that will impact our actual share usage are changes in market grant values, changes in the number of recipients, changes in our stock price, changes in the structure of our equity program, payout levels under performance awards, and forfeitures of outstanding awards. The total overhang resulting from the share request, including shares available for grant and awards outstanding under the 2022 Plan at year-end, represents approximately 4.77% of the shares of the Company’s common stock outstanding as of December 31, 2024.

#### Sound Corporate Governance Practices
The Amended 2022 Plan includes a number of features that reinforce and promote alignment of equity compensation arrangements for employees, officers, consultants and outside directors with the interests of stockholders and the Company. These features include, but are not limited to, the following:

▪ No evergreen provision. The Amended 2022 Plan does not contain an “evergreen” feature pursuant to which the shares authorized for issuance under the Amended 2022 Plan can be automatically replenished.

▪ No repricing of stock options or stock appreciation rights. Without the prior approval of stockholders, outstanding stock options and stock appreciation rights (SARs) cannot be repriced, directly or indirectly. “Reprice” means any of the following or any other action that has the same effect: (i) amending a stock option or SAR to reduce its exercise price or base price, directly or indirectly, (ii) canceling a stock option or SAR at a time when its exercise price or base price exceeds the fair market value of a share of Company common stock in exchange for cash or a stock option, SAR, award of restricted stock or other equity award, (iii) repurchasing a stock option or SAR for value (in cash or otherwise) from a participant at a time when its exercise price or base price exceeds the fair market value of a share of Company common stock, or (iv) taking any other action that is treated as a repricing under generally accepted accounting principles.

▪ No discounted stock options or stock appreciation rights. Stock options and SARs may not be granted with exercise prices or base prices, respectively, lower than the fair market value of the underlying